Rachel Dorsey
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Biosimilar rollouts: practice, pitfalls and the importance of effective communication.
Journal: Practical neurology
Published: September 02, 2025
A comparison of JC virus assay performance provided with originator and biosimilar natalizumab.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 14, 2025
Lecanemab appropriate use recommendations for clinical practice in the UK.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 25, 2025
ENTIMOS: Decision Support Tool Highlights Potential Impact of Non-intravenous Therapies for Multiple Sclerosis on Patient Care via Clinical Scenario Simulation.
Journal: PharmacoEconomics - open
Published: April 22, 2024
Oral salbutamol for symptomatic treatment in MuSK antibody-positive myasthenia gravis: a single-centre experience.
Journal: Acta neurologica Belgica
Published: October 30, 2023
Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: October 28, 2021
Development of Autoimmune Thyroid Disease in Multiple Sclerosis Patients Post-Alemtuzumab Improves Treatment Response.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 13, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026